Red cell distribution width: a novel predictive biomarker for stroke risk after transient ischaemic attack.


Journal

Annals of medicine
ISSN: 1365-2060
Titre abrégé: Ann Med
Pays: England
ID NLM: 8906388

Informations de publication

Date de publication:
12 2022
Historique:
entrez: 26 4 2022
pubmed: 27 4 2022
medline: 29 4 2022
Statut: ppublish

Résumé

Predicting the prognosis of transient ischaemic attack (TIA) is difficult for many frontline clinicians. The purpose of this study was to determine whether subsequent stroke in TIA patients can be predicted via red blood cell distribution width (RDW). A total of 360 consecutive patients with new-onset TIA in our stroke centre, were enrolled over the period studied. The patients were divided into three groups: 103 TIA patients, 206 ischaemic stroke (IS) patients and 51 patients with haemorrhagic stroke (HS) within 7 days after TIA. Complete blood count, biochemical parameters and brain imaging were performed on all patients. The mean RDW values of patients with IS and HS after TIA were significantly higher than patients with TIA (13.35 ± 1.59 vs 12.84 ± 1.19, 13.32 ± 1.08 vs 12.84 ± 1.19, respectively, all The early determination of RDW is a promising, rapid, easy and inexpensive biomarker to predict the subsequent stroke in TIA patients, especially for IS. KEY MESSAGESThe most important result of our study is to show that (1) the higher RDW, the earlier the stroke onset and (2) RDW ≥13.95% has a 2.52-fold risk of ischaemic stroke in TIA patients, and RDW ≥12.85% has a 1.51-fold risk of haemorrhagic stroke.As an economic and accessible hematological marker, baseline RDW may serve as a useful biomarker for risk stratification in TIA patients.

Identifiants

pubmed: 35471128
doi: 10.1080/07853890.2022.2059558
pmc: PMC9045760
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1167-1177

Références

Thromb Res. 2018 Apr;164:4-8
pubmed: 29438871
Stroke. 2009 Sep;40(9):3091-5
pubmed: 19520988
Lancet. 2007 Oct 20;370(9596):1432-42
pubmed: 17928046
Stroke. 2013 Sep;44(9):2579-86
pubmed: 23868277
Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):263-8
pubmed: 13679654
Int J Cardiol. 2014 Jun 1;174(1):174-6
pubmed: 24750719
J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):317-21
pubmed: 12588915
Stroke. 2001 May;32(5):1091-8
pubmed: 11340215
Cytokine. 2012 May;58(2):193-8
pubmed: 22309694
Rev Neurosci. 2012 May 03;23(3):269-78
pubmed: 22752784
Cerebrovasc Dis. 2019;48(3-6):193-199
pubmed: 31786566
Acta Neurol Belg. 2020 Apr;120(2):267-275
pubmed: 32048230
N Engl J Med. 2020 May 14;382(20):1933-1941
pubmed: 32402163
Thromb Haemost. 2015 Mar;113(3):649-54
pubmed: 25631329
Am J Med. 2015 Feb;128(2):192.e11-8
pubmed: 25447618
Int J Rheumatol. 2018 Sep 27;2018:2476239
pubmed: 30363719
Brain Sci. 2020 Mar 26;10(4):
pubmed: 32224967
Arch Intern Med. 2009 Mar 9;169(5):515-23
pubmed: 19273783
Thromb Haemost. 2012 Aug;108(2):349-56
pubmed: 22739700
Int J Cardiol. 2020 Jan 1;298:93-97
pubmed: 31272739
Lancet. 2007 Jan 27;369(9558):283-92
pubmed: 17258668
Ann Transl Med. 2020 Feb;8(4):81
pubmed: 32175374
Stroke. 2008 Jul;39(7):2177-85
pubmed: 18436889
Free Radic Biol Med. 2005 Oct 1;39(7):841-52
pubmed: 16140205
Neurol Sci. 2021 Jun;42(6):2447-2452
pubmed: 33078249
Ther Adv Neurol Disord. 2018 Aug 06;11:1756286418789340
pubmed: 30093920
Clin Hemorheol Microcirc. 2011;49(1-4):295-305
pubmed: 22214701
Stroke. 2011 Mar;42(3):799-805
pubmed: 21293024
Toxicol In Vitro. 2015 Oct;29(7):1878-86
pubmed: 26231821
Stroke. 2015 Jul;46(7):1990-2
pubmed: 26012640
Aging (Albany NY). 2020 May 23;12(10):9855-9867
pubmed: 32445553
Dig Dis Sci. 2008 Sep;53(9):2521-3
pubmed: 18259864
Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1788-93
pubmed: 18757485
Neurotherapeutics. 2016 Oct;13(4):661-670
pubmed: 27730544
Stroke. 2014 Oct;45(10):2912-7
pubmed: 25158774
Neurology. 2005 Mar 8;64(5):817-20
pubmed: 15753415
Stroke. 2006 Jul;37(7):1923-32
pubmed: 16741184
Arch Pathol Lab Med. 2009 Apr;133(4):628-32
pubmed: 19391664
Clin Nutr. 2010 Oct;29(5):600-4
pubmed: 20334961
Int J Cardiol. 2017 Jan 15;227:8-10
pubmed: 27846467
Thromb Haemost. 2016 Jan;115(1):126-34
pubmed: 26290352
Lancet Neurol. 2016 Jul;15(8):869-881
pubmed: 27180033
Stroke. 2019 Aug;50(8):2007-2015
pubmed: 31238826
Perfusion. 2005 Mar;20(2):83-90
pubmed: 15918445
J Exp Biol. 2004 Aug;207(Pt 18):3221-31
pubmed: 15299043
Semin Thromb Hemost. 2020 Jun;46(4):502-506
pubmed: 31858514
Stroke. 2012 Mar;43(3):863-5
pubmed: 22156685
Front Neurol. 2020 Nov 20;11:601695
pubmed: 33329359
Neurosci Bull. 2016 Oct;32(5):463-8
pubmed: 27250628
Free Radic Res. 2007 Dec;41(12):1364-75
pubmed: 18075839
Mol Neurobiol. 2003 Dec;28(3):229-44
pubmed: 14709787

Auteurs

Ke-Hang Xie (KH)

Department of Neurology, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, China.

Ling-Ling Liu (LL)

Department of Nephrology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.

Yun-Ru Liang (YR)

Reproductive Endocrine Center, Yangjiang Hospital of Traditional Chinese Medicine, Yangjiang, China.

Chu-Yin Su (CY)

Department of Neurology, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, China.

Hua Li (H)

Department of Neurology, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, China.

Run-Ni Liu (RN)

Department of Neurology, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, China.

Qing-Qing Chen (QQ)

Department of Neurology, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, China.

Jia-Sheng He (JS)

Department of Neurology, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, China.

Yong-Kun Ruan (YK)

Department of Neurology, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, China.

Wang-Kai He (WK)

Department of Neurology, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH